Piedāvājumi

Vēl piedāvājumi, lapa 41533

Katram piedāvājumam zemāk ir 13–97% atlaide. Cenas tiek sinhronizētas reāllaikā no pārbaudītiem veikaliem.

OppFi Inc. WT (OPFI-WT): 5 FORCES Analysis [Dec-2025 Updated]
-22%

OppFi Inc. WT (OPFI-WT): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA): Ansoff Matrix
-22%

Orange S.A. (ORA.PA): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
OppFi Inc. WT (OPFI-WT): VRIO Analysis
-22%

OppFi Inc. WT (OPFI-WT): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA): Canvas Business Model
-22%

Orange S.A. (ORA.PA): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA): BCG Matrix [Dec-2025 Updated]
-22%

Orange S.A. (ORA.PA): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA): PESTLE Analysis [Dec-2025 Updated]
-22%

Orange S.A. (ORA.PA): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA): Marketing Mix Analysis
-22%

Orange S.A. (ORA.PA): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA) DCF Valuation
-40%

Orange S.A. (ORA.PA) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Orange S.A. (ORA.PA): SWOT Analysis [Dec-2025 Updated]
-22%

Orange S.A. (ORA.PA): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Orange S.A. (ORA.PA): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): BCG Matrix [Dec-2025 Updated]
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): Ansoff Matrix
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orange S.A. (ORA.PA): VRIO Analysis
-22%

Orange S.A. (ORA.PA): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): Canvas Business Model
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): PESTLE Analysis [Dec-2025 Updated]
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): Marketing Mix Analysis
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS) DCF Valuation
-40%

Orchid Pharma Limited (ORCHPHARMA.NS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): SWOT Analysis [Dec-2025 Updated]
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orient Cement Limited (ORIENTCEM.NS): Ansoff Matrix
-22%

Orient Cement Limited (ORIENTCEM.NS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orchid Pharma Limited (ORCHPHARMA.NS): VRIO Analysis
-22%

Orchid Pharma Limited (ORCHPHARMA.NS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orient Cement Limited (ORIENTCEM.NS): Canvas Business Model
-22%

Orient Cement Limited (ORIENTCEM.NS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orient Cement Limited (ORIENTCEM.NS): BCG Matrix [Dec-2025 Updated]
-22%

Orient Cement Limited (ORIENTCEM.NS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Orient Cement Limited (ORIENTCEM.NS): PESTLE Analysis [Dec-2025 Updated]
-22%

Orient Cement Limited (ORIENTCEM.NS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN